Cargando…

A therapeutic exploratory study to determine the efficacy and safety of calcineurin-inhibitor-free de-novo immunosuppression after liver transplantation: CILT

BACKGROUND: Immunosuppression with calcineurin inhibitors (CNI) increases the risk of renal dysfunction after orthotopic liver transplantation (OLT). Controlled trials have shown improvement of renal function in patients that received delayed and/or reduced-dose CNI after OLT. Delaying immunosuppres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goralczyk, Armin D, Schnitzbauer, Andreas, Tsui, Tung Y, Ramadori, Giuliano, Lorf, Thomas, Obed, Aiman
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Study protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858131/ https://www.ncbi.nlm.nih.gov/pubmed/20380712 http://dx.doi.org/10.1186/1471-2482-10-15

Ejemplares similares

Adult Living Donor Liver Transplantation with ABO-Incompatible Grafts: A German Single Center Experience
por: Goralczyk, Armin D., et al.
Publicado: (2009)

Acute paranoid psychosis as sole clinical presentation of hepatic artery thrombosis after living donor liver transplantation
por: Goralczyk, Armin D, et al.
Publicado: (2010)

Posterior cavoplasty: a new approach to avoid venous outflow obstruction and symptoms for small-for-size syndrome in right lobe living donor liver transplantation
por: D Goralczyk, Armin, et al.
Publicado: (2011)

Liver transplantation as curative approach for advanced hepatocellular carcinoma: is it justified?
por: Obed, Aiman, et al.
Publicado: (2007)

Tissue damage with different surgical techniques in a porcine model of liver resection: implications for living-donor liver transplantation?
por: Goralczyk, Armin Dietmar, et al.
Publicado: (2010)

Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression
por: Peddi, V. Ram, et al.
Publicado: (2023)

Study Protocol: A Pilot Study to Determine the Safety and Efficacy of Induction-Therapy, De Novo MPA and Delayed mTOR-Inhibition in Liver Transplant Recipients with Impaired Renal Function. PATRON-Study
por: Schnitzbauer, Andreas A, et al.
Publicado: (2010)

Thrombolysis in Postoperative Pulmonary Embolism Following Liver Transplantation: A Case Report
por: Al-Ghamdi, Thamer H., et al.
Publicado: (2020)

Prospective evaluation of biliary reconstruction with duct-to-duct continuous suture in adult live donor liver transplantation
por: Tsui, Tung Yu, et al.
Publicado: (2010)

Immunosuppression with Calcineurin Inhibitor after Renal Transplant Failure Inhibits Allosensitization
por: López del Moral Cuesta, Covadonga, et al.
Publicado: (2020)

Case report: 8 years after liver transplantation: de novo hepatocellular carcinoma 8 months after HCV clearance through IFN-free antiviral therapy
por: Ramadori, Giuliano, et al.
Publicado: (2018)

Everolimus Based Immunosuppression Strategies in Adult Lung Transplant Recipients: Calcineurin Inhibitor Minimization Versus Calcineurin Inhibitor Elimination
por: Ivulich, Steven, et al.
Publicado: (2023)

Ischemic Reperfusion Injury After Liver Transplantation: Is There a Place for Conservative Management?
por: Obed, Aiman, et al.
Publicado: (2023)

Renal impairment after liver transplantation - a pilot trial of calcineurin inhibitor-free vs. calcineurin inhibitor sparing immunosuppression in patients with mildly impaired renal function after liver transplantation
por: Gerhardt, T, et al.
Publicado: (2009)

Long-term results of a calcineurin inhibitor-free immunosuppression based on Thymoglobulin® and mycophenolate mofetil in elderly kidney transplant recipients
por: Kamar, Nassim, et al.
Publicado: (2008)

Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients
por: Bergh, Niklas, et al.
Publicado: (2020)

The Molecular Mechanism of Substrate Engagement and Immunosuppressant Inhibition of Calcineurin
por: Grigoriu, Simina, et al.
Publicado: (2013)

Evidence for the Immunosuppressive Potential of Calcineurin Inhibitor-Sparing Regimens in Liver Transplant Recipients with Impaired Renal Function
por: Ide, Kentaro, et al.
Publicado: (2011)

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
por: Schnitzbauer, Andreas A, et al.
Publicado: (2010)

Ultra-Rapid Virological Response, Young Age, Low γ-GT/ALT-Ratio, and Absence of Steatosis Identify a Subgroup of HCV Genotype 3 Patients Who Achieve SVR with IFN-α(2a) Monotherapy
por: Amanzada, Ahmad, et al.
Publicado: (2011)

Altered regulation of Prox1-gene-expression in liver tumors
por: Dudas, Jozsef, et al.
Publicado: (2008)

Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients
por: Tawhari, Ibrahim, et al.
Publicado: (2022)

Immunosuppression Affects Neutrophil Functions: Does Calcineurin-NFAT Signaling Matter?
por: Vymazal, Ondřej, et al.
Publicado: (2021)

Specific immunosuppressive role of nanodrugs targeting calcineurin in innate myeloid cells
por: Colombo, Miriam, et al.
Publicado: (2022)

The Calcineurin Inhibitor-Sparing (CIS) Trial - individualised calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: protocol for a randomised controlled trial
por: Sommerer, Claudia, et al.
Publicado: (2014)

Dysregulation of Th17 Cells during the Early Post-Transplant Period in Patients under Calcineurin Inhibitor Based Immunosuppression
por: Chung, Byung Ha, et al.
Publicado: (2012)

Calcineurin–NFAT signalling in myeloid leucocytes: new prospects and pitfalls in immunosuppressive therapy
por: Bendickova, Kamila, et al.
Publicado: (2017)

Immunosuppressive Therapy and Nutritional Status of Patients after Kidney Transplantation: A Protocol for a Systematic Review
por: Kajdas, Aleksandra Anna, et al.
Publicado: (2023)

A Reduction of Calcineurin Inhibitors May Improve Survival in Patients with De Novo Colorectal Cancer after Liver Transplantation
por: Ossami Saidy, Ramin Raul, et al.
Publicado: (2022)

Calcineurin-inhibitor free immunosuppression after lung transplantation – a single center case-control study in 51 patients converted to Mechanistic Target of Rapamycin (mTOR) inhibitors
por: Gottlieb, Jens, et al.
Publicado: (2023)

Optimization of de novo belatacept‐based immunosuppression administered to renal transplant recipients
por: Kirk, Allan D., et al.
Publicado: (2020)

A randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients
por: Zheng, Xiang, et al.
Publicado: (2022)

FKBP12-Dependent Inhibition of Calcineurin Mediates Immunosuppressive Antifungal Drug Action in Malassezia
por: Ianiri, Giuseppe, et al.
Publicado: (2017)

Enhancing Beta Cell Replacement Therapies: Exploring Calcineurin Inhibitor-Sparing Immunosuppressive Regimens
por: Caldara, Rossana, et al.
Publicado: (2023)

A comparison of mycophenolate mofetil and calcineurin inhibitor as maintenance immunosuppression for kidney transplant recipients: A meta-analysis of randomized controlled trials
por: DENG, Jin, et al.
Publicado: (2021)

Gut microbiota transplantation for colonization of germ-free mice
por: Choo, Jocelyn M., et al.
Publicado: (2021)

Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma
por: Xing, Tonghai, et al.
Publicado: (2013)

Towards Steroid-Free Immunosuppression after Liver Transplantation
por: Zaydfudim, Victor M., et al.
Publicado: (2016)

Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients
por: de Boer, S. E., et al.
Publicado: (2021)

mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis
por: Xie, Xishao, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ado8553m37u7ss32bjc04abg57